Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations

Antonio Passaro, Tony Mok, Solange Peters, Sanjay Popat, Myung‐Ju Ahn, Filippo de Marinis